Supra®- Testosterone 400mg/ml
ACTIVE INGREDIENTS: TESTOSTERONE PROPIONATE 60mg, TESTOSTERONE PHENYLPROPIONATE 120mg, TESTOSTERONE ISOCAPROATE 120mg, TESTOSTERONE DECANOATE 100mg ACTIVE HALF-LIFE: 7-8 DAYS CLASSIFICATION: ANABOLIC STEROID DOSAGE MEN: 300-1500 MG/WEEK ACNE :YES WATER RETENTION :YES HBR :PERHAPS HEPATOXITY: NO AROMATIZATION: YES
Quant®- Equipoise 300mg/ml
ACTIVE INGREDIENT: BOLDENONE UNDECYLENATE 300mg ACTIVE HALF-LIFE: 14 DAYS CLASSIFICATION: ANABOLIC STEROID DOSAGE MEN :400-1000 MG/WEEK ACNE: RARELY WATER RETENTION: LOW HBR: NO HEPATOXITY: LOW AROMATIZATION: LOW
Supra®- Testosterone 500mg/ml (Sustanon 500)
ACTIVE INGREDIENTS: TESTOSTERONE PROPIONATE 60mg, TESTOSTERONE PHENYLPROPIONATE 120mg, TESTOSTERONE ISOCAPROATE 120mg, TESTOSTERONE DECANOATE 200mg ACTIVE HALF-LIFE: 7-8 DAYS CLASSIFICATION: ANABOLIC STEROID DOSAGE MEN: 300-1500 MG/WEEK ACNE :YES WATER RETENTION :YES HBR :PERHAPS HEPATOXITY: NO AROMATIZATION: YES
Pheno®- NPP 100mg/ml
ACTIVE HALF-LIFE: NANDROLONE PHENYLPROPIONATE 100mg ACTIVE HALF-LIFE: 5-7 DAYS CLASSIFICATION: ANABOLIC STEROID DOSAGE: 300-800 MG/WEEK ACNE: YES WATER RETENTION: LOW HBR: PERHAPS HEPATOXITY: LOW AROMATIZATION: NO
Beligas HCG 5000
CLASSIFICATION : Glycoprotein hormones, alpha polypeptide DOSAGE : 500-3000IU 1-3 times/week ACNE : Possible WATER RETENTION : No HBR : No HEPATOTOXICITY : No AROMATIZATION : No
Etho®- Trenbolone 200mg/ml
ACTIVE INGREDIENT:: TRENBOLONE ENANTHATE 200mg ACTIVE HALF-LIFE: 5-7 DAYS CLASSIFICATION: ANABOLIC STEROID DOSAGE MEN :200-600 MG/WEEK ACNE: RARELY WATER RETENTION: YES HBR :PERHAPS HEPATOXITY: YES AROMATIZATION :NO
Tesofensine, 0.25mg (50 tabs)
Active ingredient: Tesofensine Composition: Every tablet contains 250mcg of tesofensine Active life: 9 days Detection time: 2 weeks
Beligas GLP3 Retatrutide 10mg
Retatrutide is developed for weight loss. In clinical trials, it has demonstrated the potential to help individuals lose over 20% of their body weight. This is a significant breakthrough, particularly for people who have not had success with traditional weight loss methods or other weight loss medications. By targeting multiple metabolic pathways, Retatrutide offers a more comprehensive solution to managing obesity. In addition to obesity, Retatrutide is being tested for its effectiveness in type 2 diabetes management. The drug helps regulate blood sugar levels while also promoting weight loss, which is crucial for people with type 2 diabetes. With better control over glucose and weight, patients may experience improved long-term outcomes and easier management of their diabetes. Another promising area of research for Retatrutide is its potential to treat fatty liver disease. Early studies indicate that the drug may help reduce liver fat in people with obesity, potentially preventing the progression of non-alcoholic fatty liver disease (NAFLD). This dual action on both weight and liver fat makes Retatrutide a unique treatment option for those at risk of liver complications.
Beligas GLP3 Retatrutide 5mg
- GLP-3 (Glucagon-like peptide 3)
- GIP (Glucose-dependent insulinotropic polypeptide)
- GCG (Glucagon)
Etho™️ Anavar ( Oxandrolone ) 50mg (10ml Vial)
L – Carnitine 1000mg + Probiotic CLA 2.5g, 30mL (1 vial)
L-Carnitine 1g (1,000 mg) + CLA 2.5g (2,500 mg) | 30ml Vial
Carrier Oil: MCT Oil (no EO)
Enclomiphene, 12.5mg (50 Tabs)
Active ingredients: Enclomiphene Pharmacological Category: SERMs Active life: 20 hours
